Skip to content

BMY

BRISTOL MYERS SQUIBB CO

NYSE · Healthcare · Drug Manufacturers - General · US

$63.23
+2.46%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue50.0B48.2B48.3B45.0B46.2B
Cost of Revenue15.4B13.9B14.0B10.7B10.1B
Gross Profit34.6B34.3B34.3B34.3B36.0B
Operating Expenses
R&D Expense10.6B10.0B11.2B9.3B9.5B
SG&A Expense7.3B7.3B8.4B7.8B7.8B
General & Admin Expense3.5B————
Selling & Marketing Expense————7.8B
Other Expenses3.7B3.3B8.9B9.0B9.6B
Total Operating Expenses21.6B20.5B28.4B26.1B26.9B
Cost and Expenses37.0B34.5B42.4B36.8B37.1B
Operating Income (EBIT)13.0B13.7B5.9B8.2B9.1B
Non-Operating
Interest Income101.0M————
Interest Expense1.7B1.9B1.9B1.2B1.2B
Net Interest Income(1.6B)(1.9B)(1.9B)(1.2B)(1.2B)
Other Non-Op Income/Expense(1.7B)(4.4B)(14.3B)245.0M(1.4B)
Non-Operating Income (excl Interest)61.0M2.5B12.3B(1.4B)159.0M
EBT (Pre-Tax Income)11.3B9.3B(8.4B)8.4B7.7B
Income Tax Expense2.1B2.3B554.0M400.0M1.4B
Bottom Line
Net Income9.2B7.1B(8.9B)8.0B6.3B
Earnings from Cont. Ops9.2B7.1B(8.9B)8.0B6.3B
Earnings from Discont. Ops—————
Bottom Line Net Income9.2B7.1B(8.9B)8.0B6.3B
Per Share
Basic EPS$4.52$3.46($4.41)$3.88$2.97
Diluted EPS$4.51$3.45($4.41)$3.86$2.95
Revenue Per Share$24.49$23.61$23.83$21.75$21.67
Shares
Basic Shares Outstanding2.0B2.0B2.0B2.1B2.1B
Diluted Shares Outstanding2.1B2.0B2.0B2.1B2.1B
Profitability Metrics
EBITDA15.2B15.2B3.2B19.4B19.2B
D&A2.2B4.0B9.6B9.8B10.3B
EBIT13.0B11.2B(6.4B)9.6B8.9B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026